Answers are grounded in this paper and cite their sources.
Case report demonstrates significant pain relief and joint improvement in a patient with moderate-to-severe knee osteoarthritis, suggesting a viable treatment option.
BACKGROUND: Moderate-to-severe knee osteoarthritis (KOA) involves progressive cartilage degeneration, meniscal tears, synovitis, and osteophyte formation, leading to persistent pain and functional impairment. Conventional therapies often provide inadequate relief. While platelet-rich plasma (PRP) injections have emerged as a promising regenerative treatment, their efficacy is predominantly established in mild-to-moderate KOA, with limited benefits observed in moderate-to-severe cases. CASE PRESENTATION: A 57-year-old Chinese male with bilateral moderate-to-severe knee osteoarthritis was treated with ultrasound-guided PRP injections. Over a 15-month period, he received a total of 34 bilateral intra-articular injections. At the final follow-up, both NRS and WOMAC scores were significantly reduced, concurrent with enhanced joint function and quality of life. Follow-up MRI revealed improvements in intra-articular structures, including the meniscal morphology, as well as a reduction in inflammation-related parameters, such as bone marrow edema, joint effusion, infrapatellar fat pad swelling, and synovitis. CONCLUSIONS: This study concludes that ultrasound-guided long-term PRP injection is a safe and effective therapeutic strategy for moderate-to-severe knee osteoarthritis. It provides significant relief from pain, functional improvement, enhanced quality of life, and yields objective imaging evidence of joint improvement on MRI.
No takes yet. Share an insight, caveat, or question.
Iao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: